We propose a model where ASCT and/or MM disease-derived inflammation drives increased inflammatory and γc cytokine signaling and lymphopenia-induced proliferation and accelerated immunosenescence, which would mediate the dramatic loss of TN cells in MM patients and metabolic remodeling in the remaining T cells. The gene discussed is GC; the disease is lymphopenia.